Cervical cancer can be prevented and treated scoring system developed to make colposcopy objective and accurate. However, modified SCI had never used in real-world practice before Modified Swede colposcopic index, CIN2+, Colposcopy
Conditions
Interventions
Participants with abnormal cervical cytology of ASC-US or higher cytology with or without high-risk HPV infection
Diagnostic
Colposcopy group
Sponsors
HRH princess Maha Chakri Sirinhorn Medical center
Eligibility
Sex/Gender
Female
Age
25 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. non-pregnant females aged 25-65 years 2. abnormal cervical cancer screening results either from cytology of ASC-US or higher cytology or/and high-risk HPV infection 3. no previous diagnosis of CIN2+ 4. adequate colposcopy and a transformation zone type 1 or 2
Exclusion criteria
Exclusion criteria: 1. obvious cervical mass or lesion 2. colposcopic direct biopsy was not done and a colposcopic examination did not reveal any cervical lesion 3. the patient who refused treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| External validity of the modified SCI 12 months Sensitivity, specificity, positive predictive value, negative predictive value | — |
Secondary
| Measure | Time frame |
|---|---|
| inter-rater reliability 12 months intraclass correlation coefficient (ICC) ,intra-rater reliability 12 months intraclass correlation coefficient (ICC) | — |
Countries
Thailand
Contacts
Public ContactNopporn Rodpenpear
HRH princess Maha Chakri Sirinhorn Medical center
Outcome results
None listed